PRO-RIVAROXABAN
As listed in the register: PRO-RIVAROXABAN
2.5 mg · tablet
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Rivaroxaban
- Used in
- Blood, clotting and anaemia
- Made by
- Pro Doc Limitee
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (rivaroxaban). It describes the substance, not this Bulgarian product — its uses and doses can differ.
XARELTO is a selective inhibitor of FXa.
It does not require a cofactor (such as Anti-thrombin III) for activity.
Unchanged drug is excreted into urine, mainly via active tubular secretion and to a lesser extent via glomerular filtration (approximate 5:1 ratio).
For the 2.5 mg and 10 mg dose, it is estimated to be 80% to 100% and is not affected by food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-10
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (rivaroxaban). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: (A) PREMATURE DISCONTINUATION OF XARELTO INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA A.
- XARELTO is contraindicated in patients with: active pathological bleeding [see Warnings and Precautions (5.2) ] severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see Adverse Reactions (6.2) ] Active pathological bleeding ( 4 ) Severe hypersensitivity reaction to XARELTO ( 4 )
The most common adverse reactions with XARELTO were bleeding complications [see Warnings and Precautions (5.2) ].
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States18 matching products
Bulgaria10 matching products
- Enkia 2.5 mg film-coated tablets · film - coated tablets
- KARDATUXAN 2.5 mg · film - coated tablets
- Polbaxan 2.5 mg · film - coated tablets
- Rivaroxaban MSN 2.5 mg · film - coated tablets
- Rivaroxaban Teva 2.5 mg · film - coated tablets
- Rufixalo 2,5 mg · film - coated tablets
- Thinban 2,5 mg · film - coated tablets
- Xanirva 2.5 mg · film - coated tablets
European UnionNo exact match for this strength and form
Spain28 matching products
- XARELTO 2,5 mg · comprimido recubierto con película2 makers
- COAGUBAN 2,5 mg · comprimido recubierto con película
- ELMARDYA 2,5 mg · comprimido recubierto con película
- RIVAROXABAN ALEMBIC 2,5 mg · comprimido recubierto con película
- RIVAROXABÁN APC 2,5 mg · comprimido recubierto con película
- RIVAROXABAN ARISTO 2.5 mg · comprimido recubierto con película
- RIVAROXABAN BAYER 2,5 mg · comprimido recubierto con película
- RIVAROXABAN CIPLA 2,5 mg · comprimido recubierto con película
France2 matching products
Netherlands26 matching products
- Rivaroxaban Sandoz 2 2,5 mg · filmomhulde tablet4 makers
- Blomensy 2 2,5 mg · filmomhulde tablet
- Rivaroxaban Accord 2 2,5 mg · filmomhulde tablet
- Rivaroxaban AET 2 2,5 mg · filmomhulde tablet
- Rivaroxaban Amarox 2 2,5 mg · filmomhulde tablet
- Rivaroxaban Ascend 2 2,5 mg · filmomhulde tablet
- Rivaroxaban CF 2 2,5 mg · filmomhulde tablet
- Rivaroxaban Denk 2 2,5 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Pro Doc Limitee |
|---|---|
| Active substance | Rivaroxaban |
| Used in | Blood, clotting and anaemia |
| Strength | 2.5 mg |
| Form | tablet |
| Classification | B01AF01 · Blood, clotting and anaemia |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02540967 |
| DPD drug code | 102959 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.